Application of the in vitro methodology to nuclear extracts from tumor and adjacent non-tumor patient tissues led to the detection of an abnormally high rate of RNA Pol II recycling in human prostate cancer tissues that is at least partially PAF1-dependent (Fig. 5d) and consistent with their elevated PAF1 levels (Fig. 5b). This evidence concerns the gene PAF1 and prostate carcinoma.